ENTITY

BTG (BTG LN)

82
Analysis
Health Care • United Kingdom
BTG plc was an international specialist healthcare company that developed and commercialized products targeting critical care, cancer, and other disorders. Its portfolio included interventional medicine products for liver tumors, emphysema, blood clots, and varicose veins, alongside specialty pharmaceuticals. The company was headquartered in London, United Kingdom, and was founded in 1948 as the National Research Development Corporation, later becoming BTG in 1998.
more
•30 Jun 2023 10:32•Broker

Today's Dominant Ideas

Technically, the SET Index is expected to rebound further, with the resistance at 1,490/1,495 points and the support at 1,470/1,465 points, after...

Logo
93 Views
Share
bullish•Kasikornbank
•31 Jan 2023 13:25•Broker

Market Giving More Weight to 4Q22E Earnings Than FOMC Meeting

The consensus estimate calls for 253 SET-listed firms, 28.7% of the total, to report 5.7% QoQ and 33.6% YoY increases in combined net profit in...

Logo
87 Views
Share
•17 Nov 2022 12:32•Broker

Big Cap Tactical Picks (November 17, 2022)

We recommend buying KKP, the firm's earnings are expected the growth of 26.12% at bt7.9bn (consensus expected the earning will increase 1.79% in...

Logo
88 Views
Share
•11 Nov 2022 11:18•Broker

Recommendation: Buy on Weakness, Sell on Strength

The SET Index is expected to gain, with the resistance at 1,630/1,649 points and the support at 1,612 points (200-day EMA)/1,607 points (50-day...

Logo
87 Views
Share
•14 Sep 2022 10:57•Broker
Logo
85 Views
Share
x